Titre:
  • Dissecting the heterogeneity of triple-negative breast cancer.
Auteur:Metzger-Filho, Otto; Tutt, Andrew M; Azambuja, Evandro; Saini, Kamal S; Viale, Giuseppe; Loi, Sherene; Bradbury, Ian; Bliss, Judith M; Abdel Azim, Hatem Hamdy; Ellis, Paul; Di Leo, Angelo; Baselga, José; Sotiriou, Christos; Piccart-Gebhart, Martine
Informations sur la publication:Journal of clinical oncology, 30, 15, page (1879-1887)
Statut de publication:Publié, 2012-05
Sujet CREF:Cancérologie
MeSH keywords:Antineoplastic Agents -- therapeutic use
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Breast Neoplasms -- chemistry -- classification -- epidemiology -- genetics -- pathology -- therapy
Enzyme Inhibitors -- therapeutic use
Female
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Humans
Molecular Targeted Therapy
Poly(ADP-ribose) Polymerases -- antagonists & inhibitors
Prognosis
Receptor, erbB-2 -- analysis
Receptors, Estrogen -- analysis
Receptors, Progesterone -- analysis
Tumor Markers, Biological -- analysis -- genetics
Note générale:Journal Article
Research Support, Non-U.S. Gov't
Review
SCOPUS: re.j
Langue:Anglais
Identificateurs:urn:issn:0732-183X
info:doi/10.1200/JCO.2011.38.2010
info:pii/JCO.2011.38.2010
info:scp/84863994288
info:pmid/22454417